Medication-Assisted Treatment for Opioid Dependence in Twelve Step–Oriented Residential Rehabilitation Settings

World Health Organization. Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020. Geneva, Switzerland: World Health Organization; 2013.

Lozano R , Naghavi M , Foreman K , . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;280:2095–2128.

Maxwell JC . The pain reliever and heroin epidemic in the United States: shifting winds in the perfect storm. J Addict Dis. 2015;34:127–140.

Botticelli M . Addressing the epidemic of prescription opioid abuse and heroin use. https://www.whitehouse.gov/blog/2016/02/01/preventing-epidemic-opioid-abuse-and-heroin-use. Accessed March 1, 2014.

Han B , Compton WM , Jones CM , Cai R . Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003–2013. JAMA. 2015;314:1468–1478.

Cheatle M , Comer D , Wunsch M , Skoufalos A , Reddy Y . Treating pain in addicted patients: recommendations from an expert panel. Popul Health Manag. 2014;17:79–89.

Mars SG , Fessel JN , Bourgois P , Montero F , Karandinos G , Ciccarone D . Heroin-related overdose: the unexplored influences of markets, marketing and source-types in the United States. Soc Sci Med. 2015;140:44–53.

Cicero TJ , Ellis MS , Harney J. Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med. 2015;373:1789–1790.

Stinchfield R , Owen P . Hazelden's model of treatment and its outcome. Addict Behav. 1998;23:669–683.

Jonas DE , Amick HR , Feitner C , . Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systemic review and meta-analysis. JAMA. 2014;311:1889–1900.

Bell J , Trinh L , Butler B , Randall D , Rubin G. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment. Addiction. 2009;104:1193–1200.

Weiss RD , Potter JS , Fiellin DA , . Adjunctive counseling during brief and extended buprenorphine-nalaxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry. 2011;68:1238–1246.

Comer SD , Sullivan MA , Yu E , . Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2006;63:210–218.

Galanter M , Dermatis H , Post S , Santucci C . Abstinence from drugs of abuse in community-based members of Narcotics Anonymous. J Stud Alcohol Drugs. 2013;74:349–352.

Volkow ND , Frieden TR , Hyde PS , Cha SS . Medication-assisted therapies: tackling the opioid-overdose epidemic. N Engl J Med. 2014;370:2063–2066.

Gilman S , Galanter M , Dermatis H . Methadone Anonymous: a 12-step program for methadone maintained heroin addicts. Subst Abus. 2001;22:247–256.

Monico LB, Gryczynski J, Mitchell SG, Schwartz RP, O'Grady KE, Jaffe JH. Buprenorphine treatment and 12-step meeting attendance: conflicts, compatibilities, and patient outcomes. J Subst Abuse Treat. 2015;57:89–95.

Project Match Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH post treatment drinking outcomes. J Stud Alcohol. 1997;58:7–29.

Moos R , Moos B , Andrassy J . Outcomes of four treatment approaches in community residential programs for patients with substance use disorders. Psychiatr Serv. 1999;50:1577–1583.

Timko C , DeBenedetti A , Billow R . Intensive referral to 12-Step self-help groups and 6-month substance use disorder outcomes. Addiction. 2006;101:678–688.

Campbell BK , Guydish J , Le T , Wells EA , McCarty D . The relationship of therapeutic alliance and treatment delivery fidelity with treatment retention in a multisite trial of Twelve-Step facilitation. Psychol Addict Behav. 2015;29:106–113.

Kaskutas LA , Subbaraman MS , Witbrodt J , Zemore SE . Effectiveness of making Alcoholics Anonymous easier: a group format 12-step facilitation approach. J Subst Abuse Treat. 2009;37:228–239.